Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinic acetylcholine receptor alpha7 subunit (α7 nAChR) is a ligand-gated ion channel that forms functional receptors as homopentamers. It is highly permeable to calcium ions (Ca²⁺), with rapid desensitization kinetics. Activation leads to increased Ca²⁺ influx, mediating pre- and post-synaptic excitation and modulating inflammation. It is implicated in various diseases, including Alzheimer's, schizophrenia, inflammatory conditions, and cancer, making it a target for drug development.
Agonist or antagonist of nicotinic acetylcholine receptor alpha7 subunit
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinic Acetylcholine Receptor Alpha7 Subunit (α7 nAChR).